drugset / Trial / NCT06435897
Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the feasibility, safety and efficacy of mesenchymal stem cells (MSCs) in combination with CAR-T cells in treating autoimmune disease. Another goal of the study is to learn more about the safety and function of the MSCs combined with CAR-T cells and their long term effects in autoimmune disease patients.
Timeline
- Start
- 2024-05-15
- Primary completion
- 2027-07-15
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 4SCAR T cells | Cell therapy | 1e+06 cells/kg | Intravenous |
| Subject | fetal MSCs | Unknown | 3e+06 cells | Intravenous |